BRPI0411815A - vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas - Google Patents

vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas

Info

Publication number
BRPI0411815A
BRPI0411815A BRPI0411815-4A BRPI0411815A BRPI0411815A BR PI0411815 A BRPI0411815 A BR PI0411815A BR PI0411815 A BRPI0411815 A BR PI0411815A BR PI0411815 A BRPI0411815 A BR PI0411815A
Authority
BR
Brazil
Prior art keywords
combinations
meningococcal
vaccines
neisseria meningitidis
polysaccharides
Prior art date
Application number
BRPI0411815-4A
Other languages
English (en)
Inventor
Francis J Michon
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of BRPI0411815A publication Critical patent/BRPI0411815A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"VACINAS CONTRA NEISSERIA MENINGITIDIS DO TIPO Y E SUAS COMBINAçõES MENINGOCóCICAS". A presente invenção refere-se a polissacarídeos Y meningocócicos modificados (GYMP), conjugados que compreendem os polissacarídeos modificados e um carreador, vacinas para a imunização de animais homeotermos, incluindo seres humanos, contra Neisseria meningitides do Grupo Y, e métodos para produzir esses polissacarídeos modificados, os conjugados e as vacinas.
BRPI0411815-4A 2003-06-23 2004-06-23 vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas BRPI0411815A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48040503P 2003-06-23 2003-06-23
PCT/US2004/020048 WO2005000347A1 (en) 2003-06-23 2004-06-23 Vaccines against group y neisseria meningitidis and meningococcal combinations thereof

Publications (1)

Publication Number Publication Date
BRPI0411815A true BRPI0411815A (pt) 2006-08-08

Family

ID=33551914

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411815-4A BRPI0411815A (pt) 2003-06-23 2004-06-23 vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas

Country Status (9)

Country Link
US (1) US20070020293A1 (pt)
EP (2) EP1638602A1 (pt)
JP (1) JP4918356B2 (pt)
KR (1) KR101266552B1 (pt)
AU (1) AU2004251734B2 (pt)
BR (1) BRPI0411815A (pt)
CA (1) CA2530364C (pt)
MX (1) MXPA05014015A (pt)
WO (1) WO2005000347A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
PL1973564T3 (pl) 2005-12-22 2017-04-28 Glaxosmithkline Biologicals S.A. Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae
GB0607088D0 (en) * 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
US10828361B2 (en) * 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi
ES2665002T3 (es) * 2007-03-05 2018-04-24 Om Pharma Extracto bacteriano para trastornos respiratorios y procedimiento para su preparación
CN103816870B (zh) * 2008-12-03 2016-11-23 株式会社钟化 含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
WO2012117377A1 (en) 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
CN104159603A (zh) 2012-03-08 2014-11-19 诺华股份有限公司 带有tlr4激动剂的联合疫苗
US9526776B2 (en) 2012-09-06 2016-12-27 Glaxosmithkline Biologicals Sa Combination vaccines with serogroup B meningococcus and D/T/P
EP2934574A1 (en) 2012-12-18 2015-10-28 GlaxoSmithKline Biologicals SA Conjugates for protecting against diphtheria and/or tetanus
KR102906912B1 (ko) 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5714350A (en) * 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
US5425946A (en) * 1992-08-31 1995-06-20 North American Vaccine, Inc. Vaccines against group C Neisseria meningitidis
PL175595B1 (pl) * 1992-08-31 1999-01-29 North American Vaccine Inc Antygenowy/immunogenny koniugat do wytwarzania szczepionki przeciwko infekcji N.meningitidis, sposób wytwarzania antygenowego/immunogennego koniugatu oraz szczepionka przeciwko infekcji N.meningitidis
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
EP0994723A1 (en) * 1997-06-24 2000-04-26 Chiron Corporation Methods of immunizing adults using anti-meningococcal vaccine compositions
WO1999032653A1 (en) * 1997-12-23 1999-07-01 North American Vaccine, Inc. Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
JP2004505885A (ja) * 1998-08-19 2004-02-26 ノース　アメリカン　ワクチン，　インコーポレイテッド Ｎ−アクリロイル化ポリサッカリドを用いて産生されたワクチンとして有用な免疫原性β−プロピオンアミド連結ポリサッカリド−タンパク質結合体
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
OA12590A (en) * 2001-01-23 2006-06-08 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine.
AU2002309706A1 (en) * 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AU2002309259A1 (en) * 2002-05-09 2003-11-11 Massimo Porro Improved polysaccharide and glycoconjugate vaccines_____________
WO2007084856A2 (en) * 2006-01-13 2007-07-26 Baxter International Inc. Method for purifying polysaccharides

Also Published As

Publication number Publication date
US20070020293A1 (en) 2007-01-25
AU2004251734A1 (en) 2005-01-06
WO2005000347A1 (en) 2005-01-06
EP2851088A1 (en) 2015-03-25
AU2004251734B2 (en) 2010-11-04
CA2530364C (en) 2014-03-18
JP4918356B2 (ja) 2012-04-18
MXPA05014015A (es) 2006-03-17
KR20060084789A (ko) 2006-07-25
EP1638602A1 (en) 2006-03-29
KR101266552B1 (ko) 2013-05-23
CA2530364A1 (en) 2005-01-06
JP2007524623A (ja) 2007-08-30

Similar Documents

Publication Publication Date Title
PE20071058A1 (es) Vacuna de streptococcus pneumoniae
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
DK2004225T3 (da) Programmer for vaccination med meningocockonjugater
CL2016000566A1 (es) Método para para preparar una composición inmunogénica multivalente que comprende 13 conjugados de un serotipo diferente de streptococcus pneumoniae, donde cada uno de los conjugados contiene un polisacárido capsular diferente conjugado a la proteína portadora crm197. div. sol. madre n° 200600802 e hija cl 201702206.
BRPI0411815A (pt) vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
ATE463261T1 (de) Meningokokken-konjugat-impfung
BRPI0411875A (pt) método de imunização contra os sorogrupos a e c de neisseria meningitidis
CR10123A (es) Vacuna.
BRPI0607374A2 (pt) vacinas de vesìculas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
BRPI0510430A (pt) composições e métodos para vacinação mucosal
MX348734B (es) Vacunacion multiple que incluye meningococcus del serogrupo c.
CY1111814T1 (el) Ενσωματωση του εμβολιασμου μηνιγγιτιδοκοκκικων συζευματων
BRPI0612670B1 (pt) composição imunogênica, vacina a compreendendo e kit de vacina para a administração concomitante ou sequencial
BRPI0410341B8 (pt) conjugados de polissacarídeo-proteína derivatizados de meningococos multivalentes e vacina
BRPI0813307B8 (pt) composição imunogênica, vacina, e, processo para fabricar a vacina
ECSP034701A (es) Vacuna multivalente de polisacarido meningococal-conjugado de proteina
ECSP12012100A (es) Composición de vacuna conjugada de polisacárido- proteína neumocócica 15-valente referencia cruzada a solicitudes relacionadas
AR066376A1 (es) Vacuna
BRPI0801060A2 (pt) concentrado embalado, processo para preparaÇço de um concentrado embalado e uso de um concentrado
EA201591468A1 (ru) Способ лечения
BR9915330A (pt) Método para imunizar uma ave contra uma doença
DE60042489D1 (de) Impfstoff gegen neisseria infektion
BRPI0515125A (pt) conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina
BRPI0516372A (pt) conjugados de polissacarìdeo-proteìna derivatizados meningocócicos multivalentes e vacina
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: BAXTER INTERNATIONAL INC (US) , BAXTER HEALTHCARE

Free format text: SEDE DO SEGUNDO DEPOSITANTE ALTERADA CONFORME PET. NO 020100061804-RJ, DE 07/07/2010.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 39/095 (2006.01), C07H 1/00 (2006.01), A61K 3